A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

Bagnara, D. , Kaufman, M.S., Calissano, C. , Marsilio, S. , Patten, P.E. , Simone, R. , Chum, P., Yan, X.J., Allen, S.L. , Kolitz, J.E. , Baskar, S. , Rader, C. , Mellstedt, H. , Rabbani, H. , Lee, A. , Gregersen, P.K. , Rai, K.R. & Chiorazzi, N. (2011) A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood, 117, 5463–5472. Brachtl, G. , Sahakyan, K. , Denk, U. , Girbl, T. , Alinger, B. , Hofbauer, S.W. , Neureiter, D. , Hofbauer, J.P., Egle, A. , Greil, R. & Hartmann, T.N. (2011) Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells. PLoS ONE, 6, e23758. Burger, J.A. , Ghia, P., Rosenwald, A. & CaligarisCappio, F. (2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood, 114, 3367–3375. Hallaert, D.Y. , Jaspers, A. , van Noesel, C.J., van Oers, M.H. , Kater, A.P. & Eldering, E. (2008) c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. Blood, 112, 5141–5149. Hamilton, E. , Pearce, L. , Morgan, L. , Robinson, S. , Ware, V. , Brennan, P., Thomas, N.S. , Yallop, D. , Devereux, S. , Fegan, C. , Buggins, A.G. & Pepper, C. (2012) Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells. British Journal of Haematology, 158, 589–599. Herishanu, Y. , Perez-Galan, P., Liu, D. , Biancotto, A. , Pittaluga, S. , Vire, B. , Gibellini, F. , Njuguna, N. , Lee, E. , Stennett, L. , Raghavachari, N. , Liu, P., McCoy, J.P., Raffeld, M. , Stetler-Stevenson, M. , Yuan, C. , Sherry, R. , Arthur, D.C., Maric, I. , White, T. , Marti, G.E. , Munson, P., Wilson, W. H. & Wiestner, A. (2011) The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood, 117, 563–574. Hofbauer, J.P., Heyder, C. , Denk, U. , Kocher, T. , Holler, C. , Trapin, D. , Asslaber, D. , Tinhofer, I. , Greil, R. & Egle, A. (2011) Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL. Leukemia, 25, 1452–1458. Messmer, B.T. , Messmer, D. , Allen, S.L. , Kolitz, J. E. , Kudalkar, P., Cesar, D. , Murphy, E.J., Koduru, P., Ferrarini, M. , Zupo, S. , Cutrona, G. , Damle, R.N. , Wasil, T. , Rai, K.R. , Hellerstein, M.K. & Chiorazzi, N. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest, 115, 755–764. Patten, P.E. , Buggins, A.G. , Richards, J., Wotherspoon, A. , Salisbury, J., Mufti, G.J., Hamblin, T. J. & Devereux, S. (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood, 111, 5173–5181. Plander, M. , Seegers, S. , Ugocsai, P., DiermeierDaucher, S. , Ivanyi, J., Schmitz, G. , Hofstadter, F. , Schwarz, S. , Orso, E. , Knuchel, R. & Brockhoff, G. (2009) Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia, 23, 2118–2128.